| [1] Lo E H, Dalkara T, Moskowitz M A. Mechanisms, challenges and opportunities in stroke [J]. Nature Rev Neurosci, 2003, 4(5): 399-415.[2] Rashidian J, Iyirhiaro G O, Park D S. Cell cycle machinery and stroke [J]. Biochim Biophys Acta, 2007, 1772(4): 484-493.[3] Seth Love. Neuronal expression of cell cycle-related proteins after brain ischaemia in man [J]. Neuroscience Letters, 2003, 353(1): 29-32.[4] Wen Wang, Xu Jing-dong, Lei Li, et al. Neuroprotective effect of morroniside on focal cerebral ischemia in rats [J]. Brain Res Bull, 2010, 83(5):196-201. [5] Wen Wang, Fangling Sun, Yi An, et al. Morroniside protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide-induced cytotoxicity [J]. Eur J Pharmacol, 2009, 613(1-3):19-23. [6] Wen Wang, Wenting Huang, Lin Li, et al. Morroniside prevents peroxide-induced apoptosis by induction of endogenous glutathione in human neuroblastoma cells [J]. Cell Mol Neurobiol. 2008, 28 (2):293-305.[7] Longa E Z, Weinstein P R, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats [J]. Stroke, 1989, 20(1): 84- 91.[8] Bederson J B, Pitts L H, Tsuji M, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination [J]. Stroke, 1986, 17(3): 472- 476.[9] Juri Katchanov, Christoph Harms, Karen Gertz, et al. Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death[J]. J Neurosci, 2001, 21(14): 5045-5053.[10] Hitoshi Osuga, Sachiko Osuga, Fuhu Wang, et al. Cyclin-dependent kinases as a therapeutic target for stroke [J]. PNAS, 2000, 97(18): 10254-10259.[11] Yi Wen, Yang Shao-hua, Liu Ran, et al. Cell-cycle regulators are involved in transient cerebral ischemia induced neuronal apoptosis in female rats [J]. FEBS Letters, 2005, 579(21): 4591–4599. [12] Yu-Shuang Chai, Jun Hu, Fan Lei, et al. Effect of berberine on cell cycle arrest and cell survival during cerebral ischemia and reperfusion and correlations with p53/cyclin D1 and PI3K/Akt[J]. Eur J Pharmacol, 2013, 708(1-3):44-55.[13] Dai-Shi Tian, Zhi-Yuan Yu, Min-Jie Xie, et al. Suppression of astroglial scar formation and enhanced axonal regeneration associated with functional recovery in a spinal cord injury rat model by the cell cycle inhibitor olomoucine [J]. J Neurosci Res, 2006, 84(5), 1053–1063.[14] Qin Yang, En-Yin Wang, Xiao-Jiang Huang, et al. Blocking epidermal growth factor receptor attenuates reactive astrogliosis through inhibiting cell cycle progression and protects against ischemic brain injury in rats [J]. J Neurochemistry, 2011, 119(3):644-653. |
